SURF-6 inhibitors are a class of chemical compounds that specifically target the SURF-6 protein, a nucleolar protein involved in the regulation of ribosomal biogenesis and RNA processing. SURF-6 is believed to play a role in the assembly of ribosomal RNA (rRNA) and the formation of ribonucleoprotein complexes, which are essential for the production of functional ribosomes in the cell. By interacting with rRNA and other components of the nucleolus, SURF-6 helps maintain the structural integrity and function of this important cellular organelle. Inhibitors of SURF-6 are designed to disrupt its interactions or catalytic activities, impacting ribosome assembly and the overall efficiency of protein synthesis within the cell.
Chemically, SURF-6 inhibitors are often small molecules that are structured to bind to specific regions of the protein, such as those involved in RNA binding or protein-protein interactions. These inhibitors may function by blocking the binding of SURF-6 to rRNA or by altering its conformation, thus hindering its ability to support nucleolar function. Other inhibitors may interfere with its role in ribonucleoprotein complex formation, leading to downstream effects on ribosomal assembly. By inhibiting SURF-6, researchers can gain insights into the molecular mechanisms of ribosome biogenesis, RNA processing, and nucleolar organization. Studying the effects of SURF-6 inhibitors helps in understanding the broader implications of ribosomal dysfunction and how disruptions in nucleolar activities can influence cellular processes such as growth, proliferation, and protein synthesis.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
A phosphatidylinositol 3-kinase (PI3K) inhibitor that can interfere with signaling pathways upstream of SURF-6, affecting its regulation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor that, similarly to Wortmannin, disrupts PI3K-dependent pathways, potentially affecting SURF-6 activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can alter the phosphorylation status of proteins involved in the same pathways as SURF-6, potentially impacting its function. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
A MEK inhibitor that can disrupt the MAPK/ERK pathway, which may have a downstream effect on SURF-6 regulation or stability. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can modify the kinase activity in pathways associated with SURF-6, altering its activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which can affect the MAPK/ERK pathway and subsequently influence SURF-6-regulated processes. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
An inhibitor of c-Jun N-terminal kinase (JNK), which might alter signaling cascades that regulate SURF-6. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
A substance that disrupts protein transport from the endoplasmic reticulum to the Golgi apparatus, which can affect the localization and function of SURF-6. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor that leads to the elevation of cytosolic calcium levels, potentially affecting calcium-dependent regulatory mechanisms of SURF-6. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
An inhibitor of N-linked glycosylation, which can impact the folding and stability of proteins, potentially affecting SURF-6. | ||||||